Deucravacitinib – November 2022

• Brand names:
  • Sotyktu®
• Pharmaceutical Company:
  • Bristol-Myers Squibb Australia Pty Ltd
• Condition/Indication: Plaque psoriasis
• Meeting Date: November 2022
• Public Summary Document (PSD) November 2022 March 2023 PBAC Meetings - (PDF 962KB)
• Public Summary Document (PSD) November 2022 March 2023 PBAC Meetings - (Word 246KB)

Related Public Summary Document

Deucravacitinib – March 2023